Back to TWO SIGMA INVESTMENTS, LP TWO SIGMA INVESTMENTS, LP

VTGNVTGN
Showing 8 of 11 quarters

Position history for TWO SIGMA INVESTMENTS, LPTWO SIGMA INVESTMENTS, LP's holdings in VISTAGEN THERAPEUTICS INC

TWO SIGMA INVESTMENTS, LP holds 847,992 shares of VTGN (VISTAGEN THERAPEUTICS INC), worth $191,646 as of 2026-Q2. The position was increased (+80.6% shares). VTGN represents 0.0% of TWO SIGMA INVESTMENTS, LP's portfolio.

Current Value

$191,646

Current Shares

847,992

Total Value Change

+$6,405

Total Shares Change

+786,450

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
847,992
+80.6%
$191,6460.0%$0.23
35
2026-Q1
Increased
469,619
+140.1%
$268,3870.0%$0.61
38
2025-Q4
Decreased
195,570
-32.4%
$129,4480.0%$0.68
0
2025-Q3
Increased
289,409
+223.5%
$1M0.0%$3.54
40
2025-Q2
Decreased
89,451
-20.5%
$178,9020.0%$1.97
0
2025-Q1
Decreased
112,507
-18.1%
$281,2680.0%$2.59
0
2024-Q4
Increased
137,334
+123.2%
$405,1350.0%$2.81
38
2024-Q3
Decreased
61,542
-8.8%
$185,2410.0%$3.07
0

Other major holders of VTGN: Janus Henderson Group Ltd., VANGUARD GROUP INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used